Xtant Medical Holdings, Inc. (AMEX:XTNT) will be hosting a conference call at 9:00 AM eastern time on 29th October 2020, to discuss its 3Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.xtantmedical.com
Earnings Expectation
Xtant Medical Holdings, Inc. is reporting third quarter earnings results on Thursday 29th October 2020, before market open.
The consensus estimates from Thomson Reuters are loss of $ 0.11 per share from $ 16.03 million in revenue. For the full year, analysts predict revenues of $ 60.50 million, while looking forward to loss of $ 0.52 per share.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system.
